Asston Pharmaceuticals Ltd

BSE: 544445 · Pharmaceuticals & Biotechnology · 21 announcements

Share price: ₹98.15
Market cap: ₹83.55 Cr
Revenue (annual): ₹25.47 Cr
Net profit (annual): ₹3.87 Cr
P/E (TTM): 21.6×Sector 47.3×
Promoter holding: 50.66%
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Annual General Meeting 8 Board Meeting Date 3 Other Announcement 2 Financial Results 2 Capital Structure Change 2 Fund Raise 1 Debt & Borrowing 1 Board Meeting Outcome 1 Annual Report 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

29 May 2026 21:48 IST BSE

Financial Results

Asston Pharmaceuticals H2 FY26 Results: Net Profit ₹0.5 Cr, Down 75.0% YoY

Asston Pharmaceuticals Ltd reported revenue from operations of ₹10.1 Cr (+11.0% YoY) and net profit of ₹0.5 Cr (-75.0% YoY) for H2 FY26.

Key figure: Net profit ₹0.5 Cr · -75.0% YoY

Open full results → Read the filing ↗

29 May 2026 21:47 IST BSE

Financial Results

Asston Pharmaceuticals Financial Results

Asston Pharmaceuticals approved audited financial results for FY26, reporting a total income of ₹31.58 Crore. The board meeting concluded at 07:10 P.M. on May 29, 2026.

Value: ₹31.58 Cr

Read the filing ↗